GABAPENTIN
NDC 59762-5050, gabapentin, suspension, from Mylan Pharmaceuticals Inc..
- Product NDC
- 59762-5050
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021129
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59762-5050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN250 mg/5mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59762-5050-7 | 59762505007 | 1 BOTTLE, PLASTIC in 1 CARTON (59762-5050-7) / 470 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cff7de45-148b-4e96-88fd-6052bf75b5f7NADAC price for package 59762505007
GET /v1/drugs/nadac/59762505007
Use it
Look up 59762-5050 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59762-5050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59762-5050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.